Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2005 1
2006 1
2007 1
2009 6
2010 7
2011 6
2012 2
2013 5
2014 11
2015 9
2016 6
2017 7
2018 9
2019 15
2020 22
2021 21
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Results by year
Filters applied: . Clear all
Page 1
Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer.
Bardia A, Kaklamani V, Wilks S, Weise A, Richards D, Harb W, Osborne C, Wesolowski R, Karuturi M, Conkling P, Bagley RG, Wang Y, Conlan MG, Kabos P. Bardia A, et al. Among authors: wesolowski r. J Clin Oncol. 2021 Apr 20;39(12):1360-1370. doi: 10.1200/JCO.20.02272. Epub 2021 Jan 29. J Clin Oncol. 2021. PMID: 33513026 Free PMC article. Clinical Trial.
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.
Waks AG, Stover DG, Guerriero JL, Dillon D, Barry WT, Gjini E, Hartl C, Lo W, Savoie J, Brock J, Wesolowski R, Li Z, Damicis A, Philips AV, Wu Y, Yang F, Sullivan A, Danaher P, Brauer HA, Osmani W, Lipschitz M, Hoadley KA, Goldberg M, Perou CM, Rodig S, Winer EP, Krop IE, Mittendorf EA, Tolaney SM. Waks AG, et al. Among authors: wesolowski r. Clin Cancer Res. 2019 Aug 1;25(15):4644-4655. doi: 10.1158/1078-0432.CCR-19-0173. Epub 2019 May 6. Clin Cancer Res. 2019. PMID: 31061067 Free PMC article.
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
Goodwin PJ, Chen BE, Gelmon KA, Whelan TJ, Ennis M, Lemieux J, Ligibel JA, Hershman DL, Mayer IA, Hobday TJ, Bliss JM, Rastogi P, Rabaglio-Poretti M, Mukherjee SD, Mackey JR, Abramson VG, Oja C, Wesolowski R, Thompson AM, Rea DW, Stos PM, Shepherd LE, Stambolic V, Parulekar WR. Goodwin PJ, et al. Among authors: wesolowski r. JAMA. 2022 May 24;327(20):1963-1973. doi: 10.1001/jama.2022.6147. JAMA. 2022. PMID: 35608580 Clinical Trial.
Myeloid transformation by MLL-ENL depends strictly on C/EBP.
Wesolowski R, Kowenz-Leutz E, Zimmermann K, Dörr D, Hofstätter M, Slany RK, Mildner A, Leutz A. Wesolowski R, et al. Life Sci Alliance. 2020 Nov 3;4(1):e202000709. doi: 10.26508/lsa.202000709. Print 2021 Jan. Life Sci Alliance. 2020. PMID: 33144337 Free PMC article.
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor.
Mal R, Magner A, David J, Datta J, Vallabhaneni M, Kassem M, Manouchehri J, Willingham N, Stover D, Vandeusen J, Sardesai S, Williams N, Wesolowski R, Lustberg M, Ganju RK, Ramaswamy B, Cherian MA. Mal R, et al. Among authors: wesolowski r. Front Oncol. 2020 Oct 23;10:587386. doi: 10.3389/fonc.2020.587386. eCollection 2020. Front Oncol. 2020. PMID: 33194742 Free PMC article. Review.
Myeloid-derived suppressor cells in breast cancer.
Markowitz J, Wesolowski R, Papenfuss T, Brooks TR, Carson WE 3rd. Markowitz J, et al. Among authors: wesolowski r. Breast Cancer Res Treat. 2013 Jul;140(1):13-21. doi: 10.1007/s10549-013-2618-7. Epub 2013 Jul 5. Breast Cancer Res Treat. 2013. PMID: 23828498 Free PMC article. Review.
Plasmodium knowlesi as a Threat to Global Public Health.
Wesolowski R, Wozniak A, Mila-Kierzenkowska C, Szewczyk-Golec K. Wesolowski R, et al. Korean J Parasitol. 2015 Oct;53(5):575-81. doi: 10.3347/kjp.2015.53.5.575. Epub 2015 Oct 29. Korean J Parasitol. 2015. PMID: 26537037 Free PMC article. Review.
125 results